OC
OSCR icon

Oppenheimer & Co’s Oscar Health OSCR Stock Holding History

Oppenheimer & Co’s Portfolio OSCR Stock Details OSCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.94M Sell
67,854
-675
-1% -$14.5K 0.02% 652
2026
Q1 		$786K Buy
68,529
+750
+1% +$10.6K 0.01% 981
2025
Q4 		$974K Sell
67,779
-817
-1% -$14.1K 0.01% 816
2025
Q3 		$1.3M Buy
68,596
+41,234
+151% +$680K 0.02% 771
2025
Q2 		$587K Sell
27,362
-1,000
-4% -$14.9K 0.01% 1083
2025
Q1 		$372K Buy
28,362
+1,250
+5% +$18.6K 0.01% 1187
2024
Q4 		$364K Sell
27,112
-43,694
-62% -$703K 0.01% 1174
2024
Q3 		$1.5M Buy
70,806
+45,088
+175% +$812K 0.02% 639
2024
Q2 		$407K Buy
25,718
+6,268
+32% +$115K 0.01% 1074
2024
Q1 		$289K Buy
19,450
+3,350
+21% +$45.9K ﹤0.01% 1199
2023
Q4 		$147K Buy
16,100
+2,600
+19% +$17.9K ﹤0.01% 1316
2023
Q3 		$75.2K Sell
13,500
-1,000
-7% -$7K ﹤0.01% 1334
2023
Q2 		$117K Hold
14,500
– – ﹤0.01% 1343
2023
Q1 		$94.8K Buy
+14,500
New +$59.2K ﹤0.01% 1322

Other funds holding OSCR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
TCMNY
Thrive Capital Management (New York) New York $3.81B AUM 45.58% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Oppenheimer & Co's OSCR Position: Q2 2026 in Review

Oppenheimer & Co reduced its Oscar Health (OSCR) stake by 0.98% in Q2 2026, selling an estimated $14.5K and leaving 67,854 shares worth $1.94M. The position accounts for 0.02% of the portfolio, ranked #652.

Oppenheimer & Co first reported a position in OSCR in Q1 2023 and has held it in 14 quarters since. 403 funds tracked by Wall St. Rank hold OSCR as of Q2 2026.

  • Oppenheimer & Co held 67,854 shares of Oscar Health worth $1.94M as of Q2 2026.
  • Oppenheimer & Co sold 675 Oscar Health shares in Q2 2026, an estimated $14.5K.
  • Oscar Health made up 0.02% of Oppenheimer & Co's portfolio in Q2 2026, its #652 holding.
  • Oppenheimer & Co first reported a position in Oscar Health in Q1 2023 and has held it in 14 quarters since.
  • 403 funds tracked by Wall St. Rank held Oscar Health as of Q2 2026.

Based on Oppenheimer & Co's 13F filing for Q2 2026, filed 3 Aug 2026.